For complete study information, view the study on clinicaltrials.gov
Patients with Cystic Fibrosis ≥ 18 years of age planned to initiate intravenous (IV) antibiotics for a pulmonary exacerbation
Patients who have been treated with IV antibiotics within 6 weeks prior to Visit 1
CFFT Therapeutics Development Network Coordinating Center (TDNCC)
For more information, contact: Brenda Bourne 330-543-3510 or Michelle Powers 330-543-3089
Director, Lewis H Walker CF Center; Pediatric Pulmonologist; Pediatric Sleep Medicine
Lewis H. Walker, MD, Cystic Fibrosis CenterRobert T. Stone, MD, Respiratory CenterPediatric Sleep Medicine
While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...
By using this site, you consent to our use of cookies. To learn more, read our privacy policy.
